| Objective:To explore the relationship between advanced gastric cancer patients’prognosis and changes of quality of life scores during first-line chemotherapy.Methods:During September2010to June2012, new patients with advancedgastric cancer in the first affiliated hospital of Nanchang university were enrolled inthis study,170cases were finally analysed. All patients were treated with5-fluorouracil based doublets regimens and completed European Organization forResearch and Treatment of Cancer core questionnaire (EORTC QLQ-C30) atbaseline and after2cycles of chemotherapy. Meanwhile, ageã€sexã€performancestatusã€histological typeã€hemoglobinã€neutrophil to lymphocyte count ratio (NLR)ã€albuminã€lactate dehydrogenaseã€liver metastasisã€ascitesã€bone metastasisã€the numberof metastatic sitesã€response to chemotherapy were collected. The differences scoresof QOL before and after treatment were performed by T-test.Cox’s proportionalhazards models were performed to find which factor influenced patients’ survival inunivariate analyses, and multivariable analyses were then performed to controlconfounding effects of factors significantly influenced OS at a level of P values<0.05in the univariate analysis.Results: There existed differences in patients’ QOL in some domains duringchemotherapy, including global scale(P<0.001)ã€physical function(P<0.001)ã€rolefunction(P=0.011)〠social functio(P<0.001)〠pain(P<0.001)〠nausea andvomiting(P<0.001)〠appetit(P<0.001)〠constipation(P<0.001) and financeproblem(P<0.001)ï¼›univariate factors associated with patients’ survival includedchanges of scores in global scale(P=0.002)〠social function(P<0.001)〠painscale(P<0.001),and bone metastasis(P<0.001)〠PS(P<0.001)〠response tochemotherapy(P<0.001)ã€ascites(P<0.001)ã€the number of metastatic sites(P<0.001)ã€hemoglobin(P<0.001)〠liver metastasis(P<0.001)〠NLR(P=0.010)〠histologicaltype(P=0.020)ï¼›Further multivariable analyses suggested that only changes in globalscale(P=0.049) and pain scale(P=0.016)ã€response to chemotherapy(P<0.001)〠PS(P<0.001) and the number of metastatic sites(P=0.004) were related to patients’survival.Conclusion:Our exploratory study indicates that changes of scores duringfirst-line chemotherapy in global scale and pain scale are independent prognosticfactors in predicting survival in advanced gastric cancer, other independentprognostic factors included response to chemotherapyã€PS and the number ofmetastatic sites. |